+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 72Years
All Genders
ID01174121

Study Evaluating Short-Term Cultured Tumor-Infiltrating Lymphocytes with Pembrolizumab Following Lymphodepleting Chemotherapy in Metastatic Cancers

Led by National Cancer Institute (NCI) · Updated on 2026-10-23

332

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying an experimental immunotherapy using tumor-infiltrating lymphocytes TIL in adults aged 18 to 72 with metastatic cancers including digestive tract, urothelial, breast, ovarianendometrial, and endocrine tumors that have not responded to standard chemotherapy. The study aims to evaluate whether specially selected TIL can shrink tumors and to assess the safety of this treatment. This phase II trial is sponsored by the National Cancer Institute and explores combining TIL therapy with chemotherapy and pembrolizumab. Participants first undergo evaluation including scans, lab tests, and tumor removal surgery to grow the TIL cells. They may also have leukapheresis to collect additional white blood cells. After TIL cells are prepared, patients receive a lymphodepleting chemotherapy regimen followed by infusion of TIL cells and high-dose aldesleukin in the hospital, along with pembrolizumab either before cell infusion or upon disease progression depending on the group. Hospital stay for treatment lasts about 4 weeks. During the study, participants return for follow-up visits every 1 to 3 months in the first year, then every 6 months to a year while tumors shrink. Follow-up includes physical exams, side effect reviews, lab tests, and scans, taking up to two days per visit. Researchers measure tumor response rates at multiple time points after infusion and monitor safety and adverse events. Total study participation may extend for multiple years depending on response and follow-up needs.

CONDITIONS

Brief Title

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Research Team

N

NCI/Surgery Branch Recruitment Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here